| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.26T | 9.19T | 8.72T | 9.46T | 6.69T | 4.56T |
| Gross Profit | 613.73B | 689.41B | 847.12B | 794.02B | 884.18B | 559.03B |
| EBITDA | 179.60B | 267.26B | 454.88B | 396.36B | 548.73B | 247.85B |
| Net Income | 29.18B | 104.05B | 228.52B | 253.65B | 279.50B | 34.92B |
Balance Sheet | ||||||
| Total Assets | 5.26T | 4.78T | 5.01T | 4.87T | 4.60T | 3.95T |
| Cash, Cash Equivalents and Short-Term Investments | 239.90B | 165.76B | 139.32B | 105.19B | 140.28B | 131.34B |
| Total Debt | 1.60T | 1.24T | 1.34T | 1.50T | 1.36T | 1.31T |
| Total Liabilities | 3.47T | 3.04T | 3.20T | 3.24T | 3.16T | 2.74T |
| Stockholders Equity | 1.76T | 1.72T | 1.80T | 1.61T | 1.41T | 1.15T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 390.19B | 306.53B | -118.41B | 51.37B | 49.40B |
| Operating Cash Flow | 0.00 | 476.74B | 377.39B | -32.84B | 146.11B | 170.47B |
| Investing Cash Flow | 0.00 | -111.41B | -65.81B | 74.81B | -105.60B | -95.81B |
| Financing Cash Flow | 0.00 | -350.56B | -280.51B | -95.15B | -36.03B | -70.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥126.34B | 17.49 | ― | 2.57% | 7.46% | 153.98% | |
73 Outperform | ¥22.96B | 18.19 | ― | 4.50% | 13.76% | 13.58% | |
68 Neutral | ¥1.99T | 21.95 | 2.23% | 3.07% | -7.68% | -73.03% | |
68 Neutral | ¥74.44B | 32.15 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥224.75B | 12.70 | ― | 3.45% | -4.87% | 26.27% | |
56 Neutral | ¥3.85T | 11.54 | -0.15% | 2.74% | -14.13% | 33.18% |